TRAF2 and hepatocellular carcinoma: We knocked down TRAF2 in hepatocellular carcinoma HepG2 cells, and silencing TRAF2 resulted in a significant reduction in cell proliferation, intracellular lactate content, cell cycle, and migratory and invasive ability.